← Back to Clinical Trials
Recruiting NCT07497698

NCT07497698 Saffron Extract Supplementation and Sleep Quality in Middle-Aged Adults

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07497698
Status Recruiting
Phase
Sponsor Universidad de Granada
Condition Sleep
Study Type INTERVENTIONAL
Enrollment 80 participants
Start Date 2026-03-01
Primary Completion 2026-12-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 65 Years
Study Type INTERVENTIONAL
Interventions
Saffron ExtractDietary Supplement: Placebo

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 80 participants in total. It began in 2026-03-01 with a primary completion date of 2026-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This randomized, triple-blind, placebo-controlled clinical trial aims to evaluate the effects of daily saffron extract supplementation (30 mg/day) for six weeks on objective and subjective sleep quality in middle-aged adults with mild-to-moderate sleep disturbances. Secondary outcomes include heart rate variability, cognitive processing speed, emotional state, perceived health status, and biochemical stress markers.

Eligibility Criteria

Inclusion Criteria: * Age 18-65 years * Mild-to-moderate sleep disturbances * BMI between 18 and 35 kg/m² * Not receiving active pharmacological or psychological treatment for sleep disorders * Willingness to comply with study procedures Exclusion Criteria: * Severe neurological, psychiatric, or cardiovascular disorders * Diagnosed with obstructive sleep apnea, treated with CPAP * Night shift workers * Use of medications or supplements affecting sleep * Recreational drug use * Pregnancy or breastfeeding * Uncontrolled medical conditions

Contact & Investigator

Central Contact

Lucas Jurado-Fasoli, PhD

✉ juradofasoli@ugr.es

📞 +34618375662

Frequently Asked Questions

Who can join the NCT07497698 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Sleep. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07497698 currently recruiting?

Yes, NCT07497698 is actively recruiting participants. Contact the research team at juradofasoli@ugr.es for enrollment information.

Where is the NCT07497698 trial being conducted?

This trial is being conducted at Granada, Spain.

Who is sponsoring the NCT07497698 clinical trial?

NCT07497698 is sponsored by Universidad de Granada. The trial plans to enroll 80 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology